{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:11:52Z","timestamp":1789992712958,"version":"4.0.1"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11154-015-9321-4","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T01:24:13Z","timestamp":1445822653000},"page":"213-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Erectile dysfunction and its management in patients with diabetes mellitus"],"prefix":"10.1007","volume":"16","author":[{"given":"Giuseppe","family":"Defeudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Gianfrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Di Emidio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Tuccinardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pozzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,26]]},"reference":[{"key":"9321_CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1743-6109.2009.01624.x","volume":"7","author":"C Gratzke","year":"2010","unstructured":"Gratzke C, Angulo J, Chitaley K, Dai Y-T, Kim NN, Paick J-S, et al. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med. 2010;7:445\u201375.","journal-title":"J Sex Med"},{"key":"9321_CR2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0022-5347(01)66772-7","volume":"154","author":"AA Sattar","year":"1995","unstructured":"Sattar AA, Salpigides G, Vanderhaeghen JJ, Schulman CC, Wespes E. Cavernous oxygen tension and smooth muscle fibers: relation and function. J Urol. 1995;154:1736\u20139.","journal-title":"J Urol"},{"key":"9321_CR3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1464-410x.1999.00142.x","volume":"84","author":"IA Ayta","year":"1999","unstructured":"Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50\u20136.","journal-title":"BJU Int"},{"key":"9321_CR4","unstructured":"Nunes KP, Webb RC. No Title. ISBN 978-953-51-0199-4, InTech, 2012."},{"key":"9321_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/157489007780832579","volume":"2","author":"R Leite","year":"2007","unstructured":"Leite R, Giachini FRC, Carneiro FS, Nunes KP, Tostes RC, Webb RC. Targets for the treatment of erectile dysfunction: is NO\/cGMP still the answer? Recent Pat Cardiovasc Drug Discov. 2007;2:119\u201332.","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"9321_CR6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1073\/pnas.87.2.682","volume":"87","author":"DS Bredt","year":"1990","unstructured":"Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9321_CR7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1743-6109.04038.x","volume":"1","author":"I S\u00e1enz de Tejada","year":"2004","unstructured":"S\u00e1enz de Tejada I, Angulo J, Cellek S, Gonz\u00e1lez-Cadavid N, Heaton J, Pickard R, et al. Physiology of erectile function. J Sex Med. 2004;1:254\u201365.","journal-title":"J Sex Med"},{"key":"9321_CR8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/pr.111.004515","volume":"63","author":"K-E Andersson","year":"2011","unstructured":"Andersson K-E. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev. 2011;63:811\u201359.","journal-title":"Pharmacol Rev"},{"key":"9321_CR9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0031-6997(24)01503-5","volume":"53","author":"KE Andersson","year":"2001","unstructured":"Andersson KE. Pharmacology of penile erection. Pharmacol Rev. 2001;53:417\u201350.","journal-title":"Pharmacol Rev"},{"key":"9321_CR10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/molehr\/8.12.1053","volume":"8","author":"S Granchi","year":"2002","unstructured":"Granchi S, Vannelli GB, Vignozzi L, Crescioli C, Ferruzzi P, Mancina R, et al. Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. Mol Hum Reprod. 2002;8:1053\u201364.","journal-title":"Mol Hum Reprod"},{"key":"9321_CR11","doi-asserted-by":"crossref","first-page":"R1145","DOI":"10.1152\/ajpregu.00329.2003","volume":"285","author":"CJ Wingard","year":"2003","unstructured":"Wingard CJ, Husain S, Williams J, James S. RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum. Am J Physiol Regul Integr Comp Physiol. 2003;285:R1145\u201352.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"9321_CR12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/CS20050255","volume":"110","author":"L Jin","year":"2006","unstructured":"Jin L, Burnett AL. RhoA\/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights. Clin Sci (Lond). 2006;110:153\u201365.","journal-title":"Clin Sci (Lond)"},{"key":"9321_CR13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/BRS.0b013e318232601c","volume":"37","author":"MA Siddiqui","year":"2012","unstructured":"Siddiqui MA, Peng B, Shanmugam N, Yeo W, Fook-Chong S, Li Tat JC, et al. Erectile dysfunction in young surgically treated patients with lumbar spine disease: a prospective follow-up study. Spine (Phila Pa 1976). 2012;37:797\u2013801.","journal-title":"Spine (Phila Pa 1976)"},{"key":"9321_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(12)60520-0","volume":"381","author":"R Shamloul","year":"2013","unstructured":"Shamloul R, Ghanem H. Erectile dysfunction. Lancet. 2013;381:153\u201365.","journal-title":"Lancet"},{"key":"9321_CR15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12020-014-0254-6","volume":"46","author":"A Sansone","year":"2014","unstructured":"Sansone A, Romanelli F, Gianfrilli D, Lenzi A. Endocrine evaluation of erectile dysfunction. Endocrine. 2014;46:423\u201330.","journal-title":"Endocrine"},{"key":"9321_CR16","doi-asserted-by":"crossref","unstructured":"Maseroli E, Corona G, Rastrelli G, Lotti F, Cipriani S, Forti G, et al. Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study. J Sex Med. 2015.","DOI":"10.1111\/jsm.12832"},{"key":"9321_CR17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ijir.2008.43","volume":"20","author":"A Aversa","year":"2008","unstructured":"Aversa A, Rossi F, Francomano D, Bruzziches R, Bertone C, Santiemma V, et al. Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users. Int J Impot Res. 2008;20:566\u201373.","journal-title":"Int J Impot Res"},{"key":"9321_CR18","volume-title":"Management of erectile dysfunction in clinical practice","author":"C Carson","year":"2006","unstructured":"Carson C, Dean J, Wylie M. Management of erectile dysfunction in clinical practice. New York: Springer Medical Publishing; 2006."},{"key":"9321_CR19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/978-1-4614-5441-0_21","volume":"771","author":"K. Stadler","year":"2012","unstructured":"Stadler K Oxidative stress in diabetes. Adv Exp Med Biol. 2012;771:272\u201387.","journal-title":"Adv Exp Med Biol"},{"key":"9321_CR20","doi-asserted-by":"crossref","unstructured":"Napoli N, Strollo R, Paladini A, Briganti SI, Pozzilli P, Epstein S. The alliance of mesenchymal stem cells, bone, and diabetes. Int J Endocrinol. 2014;2014:690783. doi: 10.1155\/2014\/690783 .","DOI":"10.1155\/2014\/690783"},{"issue":"3","key":"9321_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0034-1394383","volume":"123","author":"ZA Kamenov","year":"2014","unstructured":"Kamenov ZA. A comprehensive review of erectile dysfunction in men with diabetes. Exp Clin Endocrinol Diabetes. 2014;123(3):141\u201358.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"9321_CR22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","volume":"108","author":"MA Creager","year":"2003","unstructured":"Creager MA, L\u00fcscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003;108:1527\u201332.","journal-title":"Circulation"},{"key":"9321_CR23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jmhg.2006.12.004","volume":"4","author":"Z Kamenov","year":"2007","unstructured":"Kamenov Z, Christov VYT. Erectile dysfunction in diabetic men \u2013 linked more to microangiopathic complications and neuropathy than to macroangiopathic disturbances. J Men\u2019s Heal Gend. 2007;4:64\u201373.","journal-title":"J Men\u2019s Heal Gend"},{"key":"9321_CR24","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1743-6109.2010.01778.x","volume":"7","author":"RW Lewis","year":"2010","unstructured":"Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED, et al. Definitions\/epidemiology\/risk factors for sexual dysfunction. J Sex Med. 2010;7:1598\u2013607.","journal-title":"J Sex Med"},{"key":"9321_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-4295(02)02102-7","volume":"61","author":"A Nicolosi","year":"2003","unstructured":"Nicolosi A, Moreira ED, Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology. 2003;61:201\u20136.","journal-title":"Urology"},{"key":"9321_CR26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5347(05)67900-1","volume":"163","author":"CB Johannes","year":"2000","unstructured":"Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69\u00a0years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163:460\u20133.","journal-title":"J Urol"},{"key":"9321_CR27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-139-3-200308050-00005","volume":"139","author":"CG Bacon","year":"2003","unstructured":"Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50\u00a0years of age: results from the health professionals follow-up study. Ann Intern Med. 2003;139:161\u20138.","journal-title":"Ann Intern Med"},{"key":"9321_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabet.2011.09.003","volume":"38","author":"V Ph\u00e9","year":"2012","unstructured":"Ph\u00e9 V, Roupr\u00eat M. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies. Diabetes Metab. 2012;38:1\u201313.","journal-title":"Diabetes Metab"},{"key":"9321_CR29","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/diacare.28.7.1739","volume":"28","author":"O Kalter-Leibovici","year":"2005","unstructured":"Kalter-Leibovici O, Wainstein J, Ziv A, Harman-Bohem I, Murad H, Raz I. Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men. Diabetes Care. 2005;28:1739\u201344.","journal-title":"Diabetes Care"},{"key":"9321_CR30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/diacare.25.2.284","volume":"25","author":"G Berardis De","year":"2002","unstructured":"De Berardis G, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH, et al. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care. 2002;25:284\u201391.","journal-title":"Diabetes Care"},{"key":"9321_CR31","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.25.8.1458","volume":"25","author":"CG Bacon","year":"2002","unstructured":"Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care. 2002;25:1458\u201363.","journal-title":"Diabetes Care"},{"key":"9321_CR32","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2337\/diacare.21.11.1973","volume":"21","author":"D Fedele","year":"1998","unstructured":"Fedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Colli E, et al. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care. 1998;21:1973\u20137.","journal-title":"Diabetes Care"},{"key":"9321_CR33","first-page":"S3","volume":"10","author":"MA Vickers","year":"2004","unstructured":"Vickers MA, Wright EA. Erectile dysfunction in the patient with diabetes mellitus. Am J Manag Care. 2004;10:S3\u201311 quiz S12\u20136.","journal-title":"Am J Manag Care"},{"key":"9321_CR34","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/jsm.12601","volume":"11","author":"G Corona","year":"2014","unstructured":"Corona G, Giorda CB, Cucinotta D, Guida P, Nada E. Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors. J Sex Med. 2014;11:2065\u201373.","journal-title":"J Sex Med"},{"key":"9321_CR35","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.juro.2010.12.098","volume":"185","author":"H Wessells","year":"2011","unstructured":"Wessells H, Penson DF, Cleary P, Rutledge BN, Lachin JM, McVary KT, et al. Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J Urol. 2011;185:1828\u201334.","journal-title":"J Urol"},{"key":"9321_CR36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdiacomp.2003.12.005","volume":"19","author":"R Klein","year":"2005","unstructured":"Klein R, Klein BEK, Moss SE. Ten-year incidence of self-reported erectile dysfunction in people with long-term type 1 diabetes. J Diabetes Complicat. 2005;19:35\u201341.","journal-title":"J Diabetes Complicat"},{"key":"9321_CR37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1464-410X.2006.06550.x","volume":"99","author":"A Al-Hunayan","year":"2007","unstructured":"Al-Hunayan A, Al-Mutar M, Kehinde EO, Thalib L, Al-Ghorory M. The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int. 2007;99:130\u20134.","journal-title":"BJU Int"},{"key":"9321_CR38","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/diacare.28.5.1201","volume":"28","author":"K Esposito","year":"2005","unstructured":"Esposito K, Giugliano F, Marted\u00ec E, Feola G, Marfella R, D\u2019Armiento M, et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care. 2005;28:1201\u20133.","journal-title":"Diabetes Care"},{"issue":"4","key":"9321_CR39","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/jsm.12828","volume":"12","author":"E Kaya","year":"2015","unstructured":"Kaya E, Sikka SC, Gur S. A comprehensive review of metabolic syndrome affecting erectile dysfunction. J Sex Med. 2015;12(4):856\u201375.","journal-title":"J Sex Med"},{"key":"9321_CR40","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.diabet.2009.06.003","volume":"35","author":"MP Hermans","year":"2009","unstructured":"Hermans MP, Ahn SA, Rousseau MF. Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes. Diabetes Metab. 2009;35:484\u20139.","journal-title":"Diabetes Metab"},{"key":"9321_CR41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.urology.2009.02.073","volume":"74","author":"Y Aslan","year":"2009","unstructured":"Aslan Y, Sezgin T, Tuncel A, Tekdogan UY, Guler S, Atan A. Is type 2 diabetes mellitus a cause of severe erectile dysfunction in patients with metabolic syndrome? Urology. 2009;74:561\u20134. doi: 10.1016\/j.urology.2009.02.073 .","journal-title":"Urology"},{"key":"9321_CR42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.ijir.3901391","volume":"18","author":"G Corona","year":"2006","unstructured":"Corona G, Mannucci E, Petrone L, Ricca V, Balercia G, Mansani R, et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res. 2006;18:190\u20137.","journal-title":"Int J Impot Res"},{"key":"9321_CR43","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2605.2007.00815.x","volume":"31","author":"AI El-Sakka","year":"2008","unstructured":"El-Sakka AI, Sayed HM, Tayeb KA. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction. Int J Androl. 2008;31:602\u20138.","journal-title":"Int J Androl"},{"key":"9321_CR44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc06-1426","volume":"30","author":"D Kapoor","year":"2007","unstructured":"Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007;30:911\u20137.","journal-title":"Diabetes Care"},{"key":"9321_CR45","doi-asserted-by":"crossref","unstructured":"Shin D, Pregenzer G, Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev. 19:5\u201311.","DOI":"10.1097\/CRD.0b013e3181fb7eb8"},{"key":"9321_CR46","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","volume":"289","author":"JC Br\u00fcning","year":"2000","unstructured":"Br\u00fcning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, et al. Role of brain insulin receptor in control of body weight and reproduction. Science. 2000;289:2122\u20135.","journal-title":"Science"},{"key":"9321_CR47","doi-asserted-by":"crossref","first-page":"e000100","DOI":"10.1136\/openhrt-2014-000100","volume":"1","author":"DS Prasad","year":"2014","unstructured":"Prasad DS, Kabir Z, Devi KR, Dash AK, Das BC. Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study. Open Hear. 2014;1:e000100.","journal-title":"Open Hear"},{"key":"9321_CR48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229\u201334.","journal-title":"N Engl J Med"},{"key":"9321_CR49","unstructured":"Sukhija R, Dhanwal D, Gambhir DS, Dewan R. Silent myocardial ischaemia in patients with type II diabetes mellitus and its relation with autonomic dysfunction. Indian Heart J. 52:540\u20136."},{"key":"9321_CR50","doi-asserted-by":"crossref","first-page":"991","DOI":"10.5551\/jat.9316","volume":"18","author":"M Fukui","year":"2011","unstructured":"Fukui M, Tanaka M, Okada H, Iwase H, Mineoka Y, Senmaru T, et al. Five-item version of the international index of erectile function correlated with albuminuria and subclinical atherosclerosis in men with type 2 diabetes. J Atheroscler Thromb. 2011;18:991\u20137.","journal-title":"J Atheroscler Thromb"},{"key":"9321_CR51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1743-6109.2005.00196.x","volume":"3","author":"G Jackson","year":"2006","unstructured":"Jackson G, Rosen RC, Kloner RA, Kostis JB. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med. 2006;3:28\u201336 discussion 36.","journal-title":"J Sex Med"},{"key":"9321_CR52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nyg\u00e5rd","year":"1997","unstructured":"Nyg\u00e5rd O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230\u20136.","journal-title":"N Engl J Med"},{"key":"9321_CR53","first-page":"1019","volume":"17","author":"C Wang","year":"2011","unstructured":"Wang C, Huang Y. [Hyperhomocysteinemia and erectile dysfunction: an update]. Zhonghua Nan Ke Xue. 2011;17:1019\u201322.","journal-title":"Zhonghua Nan Ke Xue"},{"key":"9321_CR54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1179\/016164101101198965","volume":"23","author":"MJ Hecht","year":"2001","unstructured":"Hecht MJ, Neund\u00f6rfer B, Kiesewetter F, Hilz MJ. Neuropathy is a major contributing factor to diabetic erectile dysfunction. Neurol Res. 2001;23:651\u20134.","journal-title":"Neurol Res"},{"key":"9321_CR55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1464-5491.2006.01911.x","volume":"23","author":"NC Pegge","year":"2006","unstructured":"Pegge NC, Twomey AM, Vaughton K, Gravenor MB, Ramsey MW, Price DE. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment. Diabet Med. 2006;23:873\u20138.","journal-title":"Diabet Med"},{"key":"9321_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1439-0272.2008.00799.x","volume":"40","author":"M Debono","year":"2008","unstructured":"Debono M, Cachia E, Cassar A, Calleja N, Mallia M, Vassallo J. Is erectile dysfunction a sentinel symptom for cardiovascular autonomic neuropathy in patients with type 2 diabetes? Andrologia. 2008;40:1\u20136.","journal-title":"Andrologia"},{"key":"9321_CR57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.0000133278.81226.C9","volume":"110","author":"C Gazzaruso","year":"2004","unstructured":"Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004;110:22\u20136.","journal-title":"Circulation"},{"key":"9321_CR58","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553\u201379.","journal-title":"Diabetes Care"},{"key":"9321_CR59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.ijir.3900907","volume":"14","author":"CB Bleustein","year":"2002","unstructured":"Bleustein CB, Arezzo JC, Eckholdt H, Melman A. The neuropathy of erectile dysfunction. Int J Impot Res. 2002;14:433\u20139.","journal-title":"Int J Impot Res"},{"key":"9321_CR60","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0022-5347(05)67138-8","volume":"164","author":"M Burchardt","year":"2000","unstructured":"Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, et al. Hypertension is associated with severe erectile dysfunction. J Urol. 2000;164:1188\u201391.","journal-title":"J Urol"},{"issue":"5","key":"9321_CR61","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/HJH.0000000000000519","volume":"33","author":"PE Korhonen","year":"2015","unstructured":"Korhonen PE, Ettala O, Kautiainen H, Kantola I. Factors modifying the effect of blood pressure on erectile function. J Hypertens. 2015;33(5):975\u201380.","journal-title":"J Hypertens"},{"key":"9321_CR62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0895-7061(98)00225-8","volume":"12","author":"J Jensen","year":"1999","unstructured":"Jensen J, Lendorf A, Stimpel H, Frost J, Ibsen H, Rosenkilde P. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens. 1999;12:271\u20135.","journal-title":"Am J Hypertens"},{"key":"9321_CR63","doi-asserted-by":"crossref","unstructured":"Chang S-T, Chu C-M, Hsu J-T, Lin P-C, Shee J-J. Surveillance of cardiovascular risk factors for outpatients in different erectile dysfunction severity. Int J Impot Res. 21:116\u201321.","DOI":"10.1038\/ijir.2009.1"},{"key":"9321_CR64","doi-asserted-by":"crossref","first-page":"627278","DOI":"10.1155\/2012\/627278","volume":"2012","author":"V Javaroni","year":"2012","unstructured":"Javaroni V, Neves MF. Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment. Int J Hypertens. 2012;2012:627278.","journal-title":"Int J Hypertens"},{"key":"9321_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.HYP.12.1.1","volume":"12","author":"S. Bansal","year":"1988","unstructured":"Bansal S Sexual dysfunction in hypertensive men. A critical review of the literature. Hypertension. 1988;12:1\u201310.","journal-title":"Hypertension"},{"key":"9321_CR66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-1241.2010.02563.x","volume":"65","author":"M Baumh\u00e4kel","year":"2011","unstructured":"Baumh\u00e4kel M, Schlimmer N, Kratz M, Hackett G, Hacket G, Jackson G, et al. Cardiovascular risk, drugs and erectile function\u2013a systematic analysis. Int J Clin Pract. 2011;65:289\u201398.","journal-title":"Int J Clin Pract"},{"key":"9321_CR67","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCULATIONAHA.109.864199","volume":"121","author":"M B\u00f6hm","year":"2010","unstructured":"B\u00f6hm M, Baumh\u00e4kel M, Teo K, Sleight P, Probstfield J, Gao P, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial\/Telmisartan Randomized AssessmeNt Study in ACE iNtoler. Circulation. 2010;121:1439\u201346. doi: 10.1161\/CIRCULATIONAHA.109.864199 .","journal-title":"Circulation"},{"key":"9321_CR68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002512-200421060-00003","volume":"21","author":"R Fogari","year":"2004","unstructured":"Fogari R, Zoppi A. Effect of antihypertensive agents on quality of life in the elderly. Drugs Aging. 2004;21:377\u201393.","journal-title":"Drugs Aging"},{"key":"9321_CR69","doi-asserted-by":"crossref","unstructured":"Chen Y, Cui S, Lin H, Xu Z, Zhu W, Shi L, et al. Losartan improves erectile dysfunction in diabetic patients: a clinical trial. Int J Impot Res. 24:217\u201320.","DOI":"10.1038\/ijir.2012.4"},{"key":"9321_CR70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000350955","volume":"125","author":"L Yang","year":"2013","unstructured":"Yang L, Yu J, Ma R, Zhao F, Lin X, Liu P, et al. The effect of combined antihypertensive treatment (felodipine with either irbesartan or metoprolol) on erectile function: a randomized controlled trial. Cardiology. 2013;125:235\u201341.","journal-title":"Cardiology"},{"key":"9321_CR71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/IJNRD.S40172","volume":"7","author":"AK Lim","year":"2014","unstructured":"Lim AK. Diabetic nephropathy - complications and treatment. Int J Nephrol Renov Dis. 2014;7:361\u201381. doi: 10.2147\/IJNRD.S40172 .","journal-title":"Int J Nephrol Renov Dis"},{"key":"9321_CR72","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.2337\/diabetes.51.12.3577","volume":"51","author":"C Huang","year":"2002","unstructured":"Huang C, Kim Y, Caramori MLA, Fish AJ, Rich SS, Miller ME, et al. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes. 2002;51:3577\u201381.","journal-title":"Diabetes"},{"key":"9321_CR73","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1743-6109.2011.02586.x","volume":"9","author":"Y-C Chuang","year":"2012","unstructured":"Chuang Y-C, Chung M-S, Wang P-W, Lee W-C, Chen C-D, Chang H-W, et al. Albuminuria is an independent risk factor of erectile dysfunction in men with type 2 diabetes. J Sex Med. 2012;9:1055\u201364.","journal-title":"J Sex Med"},{"key":"9321_CR74","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2362.2006.01653.x","volume":"36","author":"MCA Blans","year":"2006","unstructured":"Blans MCA, Visseren FLJ, Banga JD, Hoekstra JBL, van der Graaf Y, Diepersloot RJA, et al. Infection induced inflammation is associated with erectile dysfunction in men with diabetes. Eur J Clin Investig. 2006;36:497\u2013502.","journal-title":"Eur J Clin Investig"},{"key":"9321_CR75","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archderm.1990.01670320070011","volume":"126","author":"N Fakjian","year":"1990","unstructured":"Fakjian N, Hunter S, Cole GW, Miller J. An argument for circumcision. Prevention of balanitis in the adult. Arch Dermatol. 1990;126:1046\u20137.","journal-title":"Arch Dermatol"},{"issue":"6","key":"9321_CR76","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1743-6109.2009.01243.x","volume":"6","author":"AI TK El-Sakka","year":"2009","unstructured":"El-Sakka AITK. Vascular impairment of erection in patients with diabetes and peyronie\u2019s disease: is that accumulative? J Sex Med. 2009;6(6):1736\u201342.","journal-title":"J Sex Med"},{"issue":"1","key":"9321_CR77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1745-7262.2006.00099.x","volume":"8","author":"A Tefekli","year":"2006","unstructured":"Tefekli A, Kandirali EEB. Peyronie\u2019s disease: a silent consequence of diabetes mellitus. Asian J Androl. 2006;8(1):75\u20139.","journal-title":"Asian J Androl"},{"key":"9321_CR78","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1464-410X.2007.07274.x","volume":"101","author":"SJ Bromage","year":"2008","unstructured":"Bromage SJ, Crump A, Pearce I. Phimosis as a presenting feature of diabetes. BJU Int. 2008;101:338\u201340.","journal-title":"BJU Int"},{"key":"9321_CR79","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/01.ju.0000053241.06172.95","volume":"169","author":"G Berardis De","year":"2003","unstructured":"De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, et al. Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors. J Urol. 2003;169:1422\u20138.","journal-title":"J Urol"},{"key":"9321_CR80","doi-asserted-by":"crossref","unstructured":"McCulloch DK, Hosking DJ, Tobert A. A pragmatic approach to sexual dysfunction in diabetic men: psychosexual counselling. Diabet Med. 3:485\u20139.","DOI":"10.1111\/j.1464-5491.1986.tb00800.x"},{"key":"9321_CR81","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.2047-2927.2013.00087.x","volume":"1","author":"RA Condorelli","year":"2013","unstructured":"Condorelli RA, Calogero AE, Vicari E, Favilla V, Morgia G, Cimino S, et al. Vascular regenerative therapies for the treatment of erectile dysfunction: current approaches. Andrology. 2013;1:533\u201340.","journal-title":"Andrology"},{"key":"9321_CR82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eururo.2013.08.048","volume":"65","author":"AM Isidori","year":"2014","unstructured":"Isidori AM, Buvat J, Corona G, Goldstein I, Jannini EA, Lenzi A, Porst H, Salonia A, Traish AMMM. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol. 2014;65:99\u2013112.","journal-title":"Eur Urol"},{"issue":"5","key":"9321_CR83","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1517\/14656566.2015.1011124","volume":"16","author":"A Aversa","year":"2015","unstructured":"Aversa A, Francomano D, Lenzi A. Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients? Expert Opin Pharmacother. 2015;16(5):625\u20138.","journal-title":"Expert Opin Pharmacother"},{"key":"9321_CR84","unstructured":"Martin A Kathryn. Treatment of male sexual dysfunction 2013. http:\/\/www.uptodate.com\/contents\/evaluation-of-male-sexual-dysfunction Accessed 14 May 2014."},{"key":"9321_CR85","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/jsm.12520","volume":"11","author":"HM Schmidt","year":"2014","unstructured":"Schmidt HM, Munder T, Gerger H, Fr\u00fchauf S, Barth J. Combination of psychological intervention and phosphodiesterase-5 inhibitors for erectile dysfunction: a narrative review and meta-analysis. J Sex Med. 2014;11:1376\u201391.","journal-title":"J Sex Med"},{"key":"9321_CR86","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.281.5.421","volume":"281","author":"MS Rendell","year":"1999","unstructured":"Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA. 1999;281:421\u20136.","journal-title":"JAMA"},{"key":"9321_CR87","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/cncr.10970","volume":"95","author":"LR Schover","year":"2002","unstructured":"Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, et al. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer. 2002;95:2397\u2013407.","journal-title":"Cancer"},{"key":"9321_CR88","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0090-4295(98)00443-9","volume":"52","author":"CD Zippe","year":"1998","unstructured":"Zippe CD, Kedia AW, Kedia K, Nelson DR, Agarwal A. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology. 1998;52:963\u20136.","journal-title":"Urology"},{"key":"9321_CR89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.ijir.3900354","volume":"10","author":"A Morales","year":"1998","unstructured":"Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res. 1998;10:69\u201373 discussion 73\u20134.","journal-title":"Int J Impot Res"},{"key":"9321_CR90","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/14656566.2013.799665","volume":"14","author":"R Bruzziches","year":"2013","unstructured":"Bruzziches R, Francomano D, Gareri P, Lenzi A, Aversa A. An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors. Expert Opin Pharmacother. 2013;14:1333\u201344.","journal-title":"Expert Opin Pharmacother"},{"key":"9321_CR91","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/diacare.26.3.777","volume":"26","author":"I Goldstein","year":"2003","unstructured":"Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care. 2003;26:777\u201383.","journal-title":"Diabetes Care"},{"key":"9321_CR92","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1743-6109.2011.02401.x","volume":"8","author":"EA Jannini","year":"2011","unstructured":"Jannini EA, McMahon C, Chen J, Aversa A, Perelman M. The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J Sex Med. 2011;8:2135\u201343. doi: 10.1111\/j.1743-6109.2011.02401.x .","journal-title":"J Sex Med"},{"key":"9321_CR93","doi-asserted-by":"crossref","first-page":"e9052","DOI":"10.1161\/01.CIR.0000082691.46188.C8","volume":"107","author":"J Borer","year":"2003","unstructured":"Borer J, Armstrong P. Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003. Circulation. 2003;107:e9052. doi: 10.1161\/01.CIR.0000082691.46188.C8 .","journal-title":"Circulation"},{"key":"9321_CR94","doi-asserted-by":"crossref","first-page":"19M","DOI":"10.1016\/S0002-9149(03)00828-2","volume":"92","author":"H. Padma-Nathan","year":"2003","unstructured":"Padma-Nathan H Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction. Am J Cardiol. 2003;92:19M\u201325M.","journal-title":"Am J Cardiol"},{"key":"9321_CR95","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2013.01.031","volume":"60","author":"S Koka","year":"2013","unstructured":"Koka S, Das A, Salloum FN, Kukreja RC. Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia\/reperfusion injury in type 2 diabetic mice. Free Radic Biol Med. 2013;60:80\u20138.","journal-title":"Free Radic Biol Med"},{"key":"9321_CR96","doi-asserted-by":"crossref","unstructured":"Weeks JL, Zoraghi R, Beasley A, Sekhar KR, Francis SH, Corbin JD. High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients. Int J Impot Res. 17:5\u20139.","DOI":"10.1038\/sj.ijir.3901283"},{"key":"9321_CR97","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1743-6109.2011.02629.x","volume":"9","author":"I Goldstein","year":"2012","unstructured":"Goldstein I, McCullough AR, Jones LA, Hellstrom WJ, Bowden CH, Didonato K, et al. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med. 2012;9:1122\u201333.","journal-title":"J Sex Med"},{"key":"9321_CR98","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.mayocp.2012.06.016","volume":"87","author":"I Goldstein","year":"2012","unstructured":"Goldstein I, Jones LA, Belkoff LH, Karlin GS, Bowden CH, Peterson CA, et al. Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus. Mayo Clin Proc. 2012;87:843\u201352.","journal-title":"Mayo Clin Proc"},{"key":"9321_CR99","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.2047-2927.2013.00085.x","volume":"1","author":"M Orta\u00e7","year":"2013","unstructured":"Orta\u00e7 M, \u00c7ayan S, \u00c7ali\u015fkan MK, Yaman M\u00d6, Okutucu TM, Semerci MB, et al. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study. Andrology. 2013;1:549\u201355.","journal-title":"Andrology"},{"key":"9321_CR100","first-page":"661","volume":"7","author":"EA Salem","year":"2006","unstructured":"Salem EA, Kendirci M, Hellstrom WJG. Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. Curr Opin Investig Drugs. 2006;7:661\u20139.","journal-title":"Curr Opin Investig Drugs"},{"key":"9321_CR101","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/j.1743-6109.2011.02268.x","volume":"8","author":"DG Moon","year":"2011","unstructured":"Moon DG, Yang DY, Lee CH, Ahn TY, Min KS, Park K, et al. A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus. J Sex Med. 2011;8:2048\u201361.","journal-title":"J Sex Med"},{"key":"9321_CR102","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.urology.2012.02.014","volume":"80","author":"H Ding","year":"2012","unstructured":"Ding H, Du W, Wang H, Zhang L, Wang Z, Du C, et al. Efficacy and safety of udenafil for erectile dysfunction: a meta-analysis of randomized controlled trials. Urology. 2012;80:134\u20139.","journal-title":"Urology"},{"key":"9321_CR103","first-page":"341","volume":"10","author":"MC Cho","year":"2014","unstructured":"Cho MC, Paick J-S. Udenafil for the treatment of erectile dysfunction. Ther Clin Risk Manag. 2014;10:341\u201354.","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"9321_CR104","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/13685538.2013.858114","volume":"17","author":"W Du","year":"2013","unstructured":"Du W, Li J, Fan N, Shang P, Wang Z, Ding H. Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials. Aging Male. 2013;17(2):107\u201311.","journal-title":"Aging Male"},{"key":"9321_CR105","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1743-6109.2008.01168.x","volume":"6","author":"LS Malavige","year":"2009","unstructured":"Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009;6:1232\u201347.","journal-title":"J Sex Med"},{"key":"9321_CR106","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1517\/14656566.2014.934809","volume":"15","author":"GP Redrow","year":"2014","unstructured":"Redrow GP, Thompson CM, Wang R. Treatment strategies for diabetic patients suffering from erectile dysfunction: an update. Expert Opin Pharmacother. 2014;15:1827\u201336.","journal-title":"Expert Opin Pharmacother"},{"key":"9321_CR107","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/j.1743-6109.2009.01219.x","volume":"6","author":"C-C Lu","year":"2009","unstructured":"Lu C-C, Jiann B-P, Sun C-C, Lam H-C, Chu C-H, Lee J-K. Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med. 2009;6:1719\u201328.","journal-title":"J Sex Med"},{"key":"9321_CR108","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinternmed.2011.440","volume":"171","author":"BP Gupta","year":"2011","unstructured":"Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171:1797\u2013803.","journal-title":"Arch Intern Med"},{"key":"9321_CR109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1743-6109.2009.01458.x","volume":"7","author":"RR Wing","year":"2010","unstructured":"Wing RR, Rosen RC, Fava JL, Bahnson J, Brancati F, Gendrano Iii INC, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med. 2010;7:156\u201365.","journal-title":"J Sex Med"},{"key":"9321_CR110","first-page":"14","volume":"28","author":"AM Isidori","year":"2005","unstructured":"Isidori AM, Lenzi A. Risk factors for androgen decline in older males: lifestyle, chronic diseases and drugs. J Endocrinol Investig. 2005;28:14\u201322.","journal-title":"J Endocrinol Investig"},{"key":"9321_CR111","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.291.24.2978","volume":"291","author":"K Esposito","year":"2004","unstructured":"Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D\u2019Andrea F, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291:2978\u201384.","journal-title":"JAMA"},{"key":"9321_CR112","doi-asserted-by":"crossref","unstructured":"Vardi M, Nini A. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. Cochrane Database Syst Rev 2007:CD002187.","DOI":"10.1002\/14651858.CD002187.pub3"},{"issue":"2","key":"9321_CR113","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1743-6109.2006.00383.x","volume":"4","author":"E. Cheng","year":"2007","unstructured":"Cheng E Real-life safety and efficacy of vardenafil in the treatment of erectile dysfunction-results from 30,010\u00a0U.S. patients. J Sex Med. 2007;4(2):432\u20139.","journal-title":"J Sex Med"},{"key":"9321_CR114","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s00125-004-1549-6","volume":"47","author":"V Fonseca","year":"2004","unstructured":"Fonseca V, Seftel A, Denne J, Fredlund P. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia. 2004;47:1914\u201323.","journal-title":"Diabetologia"},{"key":"9321_CR115","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.ijir.3900910","volume":"14","author":"MA Vickers","year":"2002","unstructured":"Vickers MA, Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res. 2002;14:466\u201371.","journal-title":"Int J Impot Res"},{"key":"9321_CR116","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1743-6109.2009.01375.x","volume":"6","author":"EA Jannini","year":"2009","unstructured":"Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, et al. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. J Sex Med. 2009;6:2547\u201360.","journal-title":"J Sex Med"},{"key":"9321_CR117","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.ijir.3901337","volume":"17","author":"S Israilov","year":"2005","unstructured":"Israilov S, Shmuely J, Niv E, Engelstein D, Livne P, Boniel J. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus. Int J Impot Res. 2005;17:431\u20136.","journal-title":"Int J Impot Res"},{"key":"9321_CR118","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1185\/030079906X148256","volume":"22","author":"L. Blonde","year":"2006","unstructured":"Blonde L Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials. Curr Med Res Opin. 2006;22:2111\u201320.","journal-title":"Curr Med Res Opin"},{"key":"9321_CR119","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s001250100656","volume":"44","author":"AJ Boulton","year":"2001","unstructured":"Boulton AJ, Selam JL, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia. 2001;44:1296\u2013301.","journal-title":"Diabetologia"},{"key":"9321_CR120","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1442-2042.2006.01480.x","volume":"13","author":"N Ishii","year":"2006","unstructured":"Ishii N, Nagao K, Fujikawa K, Tachibana T, Iwamoto Y, Kamidono S. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction. Int J Urol. 2006;13:1066\u201372.","journal-title":"Int J Urol"},{"key":"9321_CR121","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1743-6109.2006.00295.x","volume":"3","author":"D Ziegler","year":"2006","unstructured":"Ziegler D, Merfort F, van Ahlen H, Yassin A, Reblin T, Neureither M. Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction. J Sex Med. 2006;3:883\u201391.","journal-title":"J Sex Med"},{"key":"9321_CR122","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1743-6109.2006.00249.x","volume":"3","author":"J Buvat","year":"2006","unstructured":"Buvat J, van Ahlen H, Schmitt H, Chan M, Kuepfer C, Varanese L. Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries. J Sex Med. 2006;3:512\u201320.","journal-title":"J Sex Med"},{"key":"9321_CR123","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1464-5491.2007.02338.x","volume":"25","author":"D Hatzichristou","year":"2008","unstructured":"Hatzichristou D, Gambla M, Rubio-Aurioles E, Buvat J, Brock GB, Spera G, et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med. 2008;25:138\u201346.","journal-title":"Diabet Med"},{"key":"9321_CR124","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1177\/1060028013501989","volume":"47","author":"JA Kyle","year":"2013","unstructured":"Kyle JA, Brown DA, Hill JK. Avanafil for erectile dysfunction. Ann Pharmacother. 2013;47:1312\u201320.","journal-title":"Ann Pharmacother"},{"key":"9321_CR125","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/jsm.12146","volume":"10","author":"G Hackett","year":"2013","unstructured":"Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med. 2013;10:1612\u201327.","journal-title":"J Sex Med"},{"key":"9321_CR126","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","volume":"34","author":"TH Jones","year":"2011","unstructured":"Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study). Diabetes Care. 2011;34:828\u201337.","journal-title":"Diabetes Care"},{"key":"9321_CR127","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/jsm.12315","volume":"10","author":"EA Jannini","year":"2013","unstructured":"Jannini EA, Isidori AM, Aversa A, Lenzi A, Althof SE. Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctions. J Sex Med. 2013;10:2359\u201369.","journal-title":"J Sex Med"},{"key":"9321_CR128","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-157-10-201211200-00004","volume":"157","author":"M Spitzer","year":"2012","unstructured":"Spitzer M, Basaria S, Travison TG, Davda MN, Paley A, Cohen B, et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med. 2012;157:681\u201391.","journal-title":"Ann Intern Med"},{"key":"9321_CR129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1743-6109.2010.01956.x","volume":"8","author":"J Buvat","year":"2011","unstructured":"Buvat J, Montorsi F, Maggi M, Porst H, Kaipia A, Colson MH, et al. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1\u00a0% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). J Sex Med. 2011;8:284\u201393.","journal-title":"J Sex Med"},{"key":"9321_CR130","first-page":"73","volume":"28","author":"AM Isidori","year":"2005","unstructured":"Isidori AM, Giannetta E, Pozza C, Bonifacio V, Isidori A. Androgens, cardiovascular disease and osteoporosis. J Endocrinol Investig. 2005;28:73\u20139.","journal-title":"J Endocrinol Investig"},{"key":"9321_CR131","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1517\/14740338.2014.950653","volume":"13","author":"G Corona","year":"2014","unstructured":"Corona G, Maseroli E, Rastrelli G, Isidori AM, Sforza A, Mannucci E, et al. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf. 2014;13:1327\u201351.","journal-title":"Expert Opin Drug Saf"},{"key":"9321_CR132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","volume":"336","author":"H Padma-Nathan","year":"1997","unstructured":"Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med. 1997;336:1\u20137.","journal-title":"N Engl J Med"},{"key":"9321_CR133","first-page":"727","volume":"29","author":"MK Li","year":"2000","unstructured":"Li MK, Lim PH, Wong MY, Fok A, Chia SJ, Consigliere D, et al. Transurethral alprostadil for the treatment of erectile dysfunction: results of a multicentre trial. Ann Acad Med Singap. 2000;29:727\u201331.","journal-title":"Ann Acad Med Singap"},{"key":"9321_CR134","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14656566.2014.873789","volume":"15","author":"V Hanchanale","year":"2014","unstructured":"Hanchanale V, Eardley I. Alprostadil for the treatment of impotence. Expert Opin Pharmacother. 2014;15:421\u20138.","journal-title":"Expert Opin Pharmacother"},{"key":"9321_CR135","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2165\/11641380-000000000-00000","volume":"72","author":"P Costa","year":"2012","unstructured":"Costa P, Potempa A-J. Intraurethral alprostadil for erectile dysfunction: a review of the literature. Drugs. 2012;72:2243\u201354.","journal-title":"Drugs"},{"key":"9321_CR136","first-page":"CD001784","volume":"2","author":"R Urciuoli","year":"2004","unstructured":"Urciuoli R, Cantisani TA, Carlini M, Giuglietti M, Botti FM. Prostaglandin E1 for treatment of erectile dysfunction. Cochrane Database Syst Rev. 2004;2:CD001784.","journal-title":"Cochrane Database Syst Rev"},{"key":"9321_CR137","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1159\/000049806","volume":"40","author":"P Perimenis","year":"2001","unstructured":"Perimenis P, Gyftopoulos K, Athanasopoulos A, Barbalias G. Diabetic impotence treated by intracavernosal injections: high treatment compliance and increasing dosage of vaso-active drugs. Eur Urol. 2001;40:398\u2013402 discussion 403.","journal-title":"Eur Urol"},{"key":"9321_CR138","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1464-410X.2012.11080.x","volume":"110","author":"PG Coombs","year":"2012","unstructured":"Coombs PG, Heck M, Guhring P, Narus J, Mulhall JP. A review of outcomes of an intracavernosal injection therapy programme. BJU Int. 2012;110:1787\u201391.","journal-title":"BJU Int"},{"key":"9321_CR139","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2014.10.003","volume":"147","author":"A Das","year":"2014","unstructured":"Das A, Durrant D, Salloum FN, Xi L, Kukreja RC. PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer. Pharmacol Ther. 2014;147:12\u201321.","journal-title":"Pharmacol Ther"},{"key":"9321_CR140","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.111.063412","volume":"125","author":"E Giannetta","year":"2012","unstructured":"Giannetta E, Isidori AM, Galea N, Carbone I, Mandosi E, Vizza CD, et al. Chronic inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging. Circulation. 2012;125:2323\u201333.","journal-title":"Circulation"},{"key":"9321_CR141","doi-asserted-by":"crossref","first-page":"H1558","DOI":"10.1152\/ajpheart.00865.2013","volume":"306","author":"S Koka","year":"2014","unstructured":"Koka S, Aluri HS, Xi L, Lesnefsky EJ, Kukreja RC. Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO\/SIRT1\/PGC-1\u03b1 signaling. Am J Physiol Heart Circ Physiol. 2014;306:H1558\u201368.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9321_CR142","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2164\/jandrol.111.013367","volume":"33","author":"L Deyoung","year":"2012","unstructured":"Deyoung L, Chung E, Kovac JR, Romano W, Brock GB. Daily use of sildenafil improves endothelial function in men with type 2 diabetes. J Androl. 2012;33:176\u201380.","journal-title":"J Androl"},{"key":"9321_CR143","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","volume":"113","author":"J Kim","year":"2006","unstructured":"Kim J, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113:1888\u2013904.","journal-title":"Circulation"},{"key":"9321_CR144","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0735-1097(95)00522-6","volume":"27","author":"SB Williams","year":"1996","unstructured":"Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"9321_CR145","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1517\/14656566.2011.600306","volume":"12","author":"RA Kloner","year":"2011","unstructured":"Kloner RA, Comstock G, Levine LA, Tiger S, Stecher VJ. Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors. Expert Opin Pharmacother. 2011;12:2297\u2013313.","journal-title":"Expert Opin Pharmacother"},{"key":"9321_CR146","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/diacare.25.8.1336","volume":"25","author":"C Desouza","year":"2002","unstructured":"Desouza C, Parulkar A, Lumpkin D, Akers D, Fonseca VA. Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care. 2002;25:1336\u20139.","journal-title":"Diabetes Care"},{"key":"9321_CR147","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1464-5491.2007.02298.x","volume":"25","author":"A Aversa","year":"2008","unstructured":"Aversa A, Vitale C, Volterrani M, Fabbri A, Spera G, Fini M, et al. Chronic administration of Sildenafil improves markers of endothelial function in men with type 2 diabetes. Diabet Med. 2008;25:37\u201344.","journal-title":"Diabet Med"},{"key":"9321_CR148","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/dmrr.921","volume":"25","author":"A Stirban","year":"2009","unstructured":"Stirban A, Laude D, Elghozi J-L, Sander D, Agelink MW, Hilz MJ, et al. Acute effects of sildenafil on flow mediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients. Diabetes Metab Res Rev. 2009;25:136\u201343.","journal-title":"Diabetes Metab Res Rev"},{"key":"9321_CR149","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/sj.bjp.0707459","volume":"153","author":"A Sch\u00e4fer","year":"2008","unstructured":"Sch\u00e4fer A, Fraccarollo D, Pf\u00f6rtsch S, Flierl U, Vogt C, Pfrang J, et al. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Br J Pharmacol. 2008;153:886\u201393.","journal-title":"Br J Pharmacol"},{"key":"9321_CR150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.ijir.3901513","volume":"19","author":"A Aversa","year":"2007","unstructured":"Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res. 2007;19:200\u20137.","journal-title":"Int J Impot Res"},{"key":"9321_CR151","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.diabres.2007.02.006","volume":"78","author":"F Grover-P\u00e1ez","year":"2007","unstructured":"Grover-P\u00e1ez F, Villegas Rivera G, Guill\u00e9n OR. Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes. Diabetes Res Clin Pract. 2007;78:136\u201340.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"9321_CR152","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1530\/EJE-14-0700","volume":"172","author":"D Santi","year":"2015","unstructured":"Santi D, Giannetta E, Isidori AM, Vitale C, Aversa A, Simoni M. THERAPY OF ENDOCRINE DISEASE: effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis. Eur J Endocrinol. 2015;172(3):R103\u201314.","journal-title":"Eur J Endocrinol"},{"key":"9321_CR153","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2004.10.002","volume":"47","author":"GMC Rosano","year":"2005","unstructured":"Rosano GMC, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol. 2005;47:214\u201320 discussion 220\u20132.","journal-title":"Eur Urol"},{"key":"9321_CR154","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2840-11-89","volume":"11","author":"G Mieren Van der","year":"2012","unstructured":"Van der Mieren G, Nevelsteen I, Vanderper A, Oosterlinck W, Flameng W, Herijgers P. Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury. Cardiovasc Diabetol. 2012;11:89.","journal-title":"Cardiovasc Diabetol"},{"key":"9321_CR155","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/ars.2010.3343","volume":"14","author":"K Przyklenk","year":"2011","unstructured":"Przyklenk K, Maynard M, Greiner DL, Whittaker P. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal. 2011;14:781\u201390.","journal-title":"Antioxid Redox Signal"},{"key":"9321_CR156","volume":"7","author":"A Varma","year":"2012","unstructured":"Varma A, Das A, Hoke NN, Durrant DE, Salloum FN, Kukreja RC. Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice. PLoS One. 2012;7:e45243.","journal-title":"PLoS One"},{"key":"9321_CR157","first-page":"e30","volume":"16","author":"RC Kukreja","year":"2011","unstructured":"Kukreja RC, Salloum FN, Das A, Koka S, Ockaili RA, Xi L. Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases. Exp Clin Cardiol. 2011;16:e30\u20135.","journal-title":"Exp Clin Cardiol"},{"key":"9321_CR158","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.322.7287.651","volume":"322","author":"SA Shakir","year":"2001","unstructured":"Shakir SA, Wilton LV, Boshier A, Layton D, Heeley E. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England. BMJ. 2001;322:651\u20132.","journal-title":"BMJ"},{"key":"9321_CR159","doi-asserted-by":"crossref","unstructured":"Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006;367:356\u201367.","DOI":"10.1016\/S0140-6736(06)68074-4"},{"key":"9321_CR160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/eurjhf\/hfr147","volume":"14","author":"M Guazzi","year":"2012","unstructured":"Guazzi M, Vicenzi M, Arena R. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study. Eur J Heart Fail. 2012;14:82\u201390.","journal-title":"Eur J Heart Fail"},{"key":"9321_CR161","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1464-5491.2003.01084.x","volume":"21","author":"D Aronson","year":"2004","unstructured":"Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, et al. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med. 2004;21:39\u201344.","journal-title":"Diabet Med"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-015-9321-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-015-9321-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-015-9321-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:12:12Z","timestamp":1748650332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-015-9321-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":161,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["9321"],"URL":"https:\/\/doi.org\/10.1007\/s11154-015-9321-4","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}